The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Viral Disease Diagnosis Market Research Report 2025
Synopsis
Viral Disease Diagnosis is based on clinical features and pathological data to determine the possible infection of viruses. Then according to the biological characteristics of suspicious viruses, immune response and clinical process, combined with the patient's current time.
The global Viral Disease Diagnosis market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Viral Disease Diagnosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral Disease Diagnosis.
Report Scope
The Viral Disease Diagnosis market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Viral Disease Diagnosis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Viral Disease Diagnosis companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Cepheid
Thermo Fischer Scientific
Becton Dickinson
Novartis Diagnostics
Abbott Laboratories
Roche Diagnostics
bioMerieux
Affymetrix
Siemens
Segment by Type
Serodiagnostic Tests
Specimen Examination
Viral Isolation
Segment by Application
Hospitals
Physician Clinics
Nursing Homes
Commercial Laboratories
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Viral Disease Diagnosis companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Viral Disease Diagnosis is based on clinical features and pathological data to determine the possible infection of viruses. Then according to the biological characteristics of suspicious viruses, immune response and clinical process, combined with the patient's current time.
The global Viral Disease Diagnosis market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Viral Disease Diagnosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral Disease Diagnosis.
Report Scope
The Viral Disease Diagnosis market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Viral Disease Diagnosis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Viral Disease Diagnosis companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Cepheid
Thermo Fischer Scientific
Becton Dickinson
Novartis Diagnostics
Abbott Laboratories
Roche Diagnostics
bioMerieux
Affymetrix
Siemens
Segment by Type
Serodiagnostic Tests
Specimen Examination
Viral Isolation
Segment by Application
Hospitals
Physician Clinics
Nursing Homes
Commercial Laboratories
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Viral Disease Diagnosis companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Viral Disease Diagnosis Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Serodiagnostic Tests
1.2.3 Specimen Examination
1.2.4 Viral Isolation
1.3 Market by Application
1.3.1 Global Viral Disease Diagnosis Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Physician Clinics
1.3.4 Nursing Homes
1.3.5 Commercial Laboratories
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Viral Disease Diagnosis Market Perspective (2019-2030)
2.2 Viral Disease Diagnosis Growth Trends by Region
2.2.1 Global Viral Disease Diagnosis Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Viral Disease Diagnosis Historic Market Size by Region (2019-2024)
2.2.3 Viral Disease Diagnosis Forecasted Market Size by Region (2025-2030)
2.3 Viral Disease Diagnosis Market Dynamics
2.3.1 Viral Disease Diagnosis Industry Trends
2.3.2 Viral Disease Diagnosis Market Drivers
2.3.3 Viral Disease Diagnosis Market Challenges
2.3.4 Viral Disease Diagnosis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Viral Disease Diagnosis Players by Revenue
3.1.1 Global Top Viral Disease Diagnosis Players by Revenue (2019-2024)
3.1.2 Global Viral Disease Diagnosis Revenue Market Share by Players (2019-2024)
3.2 Global Viral Disease Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Viral Disease Diagnosis Revenue
3.4 Global Viral Disease Diagnosis Market Concentration Ratio
3.4.1 Global Viral Disease Diagnosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Viral Disease Diagnosis Revenue in 2023
3.5 Viral Disease Diagnosis Key Players Head office and Area Served
3.6 Key Players Viral Disease Diagnosis Product Solution and Service
3.7 Date of Enter into Viral Disease Diagnosis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Viral Disease Diagnosis Breakdown Data by Type
4.1 Global Viral Disease Diagnosis Historic Market Size by Type (2019-2024)
4.2 Global Viral Disease Diagnosis Forecasted Market Size by Type (2025-2030)
5 Viral Disease Diagnosis Breakdown Data by Application
5.1 Global Viral Disease Diagnosis Historic Market Size by Application (2019-2024)
5.2 Global Viral Disease Diagnosis Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Viral Disease Diagnosis Market Size (2019-2030)
6.2 North America Viral Disease Diagnosis Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Viral Disease Diagnosis Market Size by Country (2019-2024)
6.4 North America Viral Disease Diagnosis Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Viral Disease Diagnosis Market Size (2019-2030)
7.2 Europe Viral Disease Diagnosis Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Viral Disease Diagnosis Market Size by Country (2019-2024)
7.4 Europe Viral Disease Diagnosis Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Viral Disease Diagnosis Market Size (2019-2030)
8.2 Asia-Pacific Viral Disease Diagnosis Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Viral Disease Diagnosis Market Size by Region (2019-2024)
8.4 Asia-Pacific Viral Disease Diagnosis Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Viral Disease Diagnosis Market Size (2019-2030)
9.2 Latin America Viral Disease Diagnosis Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Viral Disease Diagnosis Market Size by Country (2019-2024)
9.4 Latin America Viral Disease Diagnosis Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Viral Disease Diagnosis Market Size (2019-2030)
10.2 Middle East & Africa Viral Disease Diagnosis Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Viral Disease Diagnosis Market Size by Country (2019-2024)
10.4 Middle East & Africa Viral Disease Diagnosis Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Cepheid
11.1.1 Cepheid Company Detail
11.1.2 Cepheid Business Overview
11.1.3 Cepheid Viral Disease Diagnosis Introduction
11.1.4 Cepheid Revenue in Viral Disease Diagnosis Business (2019-2024)
11.1.5 Cepheid Recent Development
11.2 Thermo Fischer Scientific
11.2.1 Thermo Fischer Scientific Company Detail
11.2.2 Thermo Fischer Scientific Business Overview
11.2.3 Thermo Fischer Scientific Viral Disease Diagnosis Introduction
11.2.4 Thermo Fischer Scientific Revenue in Viral Disease Diagnosis Business (2019-2024)
11.2.5 Thermo Fischer Scientific Recent Development
11.3 Becton Dickinson
11.3.1 Becton Dickinson Company Detail
11.3.2 Becton Dickinson Business Overview
11.3.3 Becton Dickinson Viral Disease Diagnosis Introduction
11.3.4 Becton Dickinson Revenue in Viral Disease Diagnosis Business (2019-2024)
11.3.5 Becton Dickinson Recent Development
11.4 Novartis Diagnostics
11.4.1 Novartis Diagnostics Company Detail
11.4.2 Novartis Diagnostics Business Overview
11.4.3 Novartis Diagnostics Viral Disease Diagnosis Introduction
11.4.4 Novartis Diagnostics Revenue in Viral Disease Diagnosis Business (2019-2024)
11.4.5 Novartis Diagnostics Recent Development
11.5 Abbott Laboratories
11.5.1 Abbott Laboratories Company Detail
11.5.2 Abbott Laboratories Business Overview
11.5.3 Abbott Laboratories Viral Disease Diagnosis Introduction
11.5.4 Abbott Laboratories Revenue in Viral Disease Diagnosis Business (2019-2024)
11.5.5 Abbott Laboratories Recent Development
11.6 Roche Diagnostics
11.6.1 Roche Diagnostics Company Detail
11.6.2 Roche Diagnostics Business Overview
11.6.3 Roche Diagnostics Viral Disease Diagnosis Introduction
11.6.4 Roche Diagnostics Revenue in Viral Disease Diagnosis Business (2019-2024)
11.6.5 Roche Diagnostics Recent Development
11.7 bioMerieux
11.7.1 bioMerieux Company Detail
11.7.2 bioMerieux Business Overview
11.7.3 bioMerieux Viral Disease Diagnosis Introduction
11.7.4 bioMerieux Revenue in Viral Disease Diagnosis Business (2019-2024)
11.7.5 bioMerieux Recent Development
11.8 Affymetrix
11.8.1 Affymetrix Company Detail
11.8.2 Affymetrix Business Overview
11.8.3 Affymetrix Viral Disease Diagnosis Introduction
11.8.4 Affymetrix Revenue in Viral Disease Diagnosis Business (2019-2024)
11.8.5 Affymetrix Recent Development
11.9 Siemens
11.9.1 Siemens Company Detail
11.9.2 Siemens Business Overview
11.9.3 Siemens Viral Disease Diagnosis Introduction
11.9.4 Siemens Revenue in Viral Disease Diagnosis Business (2019-2024)
11.9.5 Siemens Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
